← Evidence map

ArticleCNS drugs2022

Correction to: Inebilizumab: A Review in Neuromyelitis Optica Spectrum Disorder.

Tina Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36190651